Recombinant Mouse CD226/DNAM-1 Protein, N-His from ProteoGenix; catalogue ARO-P11075; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Recombinant Mouse CD226/DNAM-1 Protein is a genetically engineered protein that is derived from the mouse CD226 gene. This protein plays a crucial role in immune response and is involved in the regulation of T cell activation and cytotoxicity. In this article, we will discuss the structure, activity and applications of this recombinant protein.
The recombinant mouse CD226/DNAM-1 protein is a type I transmembrane glycoprotein that belongs to the immunoglobulin superfamily. It is composed of a single extracellular domain, a transmembrane domain and a cytoplasmic tail. The extracellular domain consists of two immunoglobulin-like domains, an N-terminal V-type domain and a C-terminal C2-type domain. These domains are responsible for binding to ligands and interacting with other proteins.
The main function of CD226/DNAM-1 protein is to regulate T cell activation and cytotoxicity. It acts as a co-stimulatory molecule on T cells and enhances their response to antigen stimulation. This protein also plays a crucial role in the activation of natural killer (NK) cells and promotes their cytotoxicity against target cells.
CD226/DNAM-1 protein has been shown to interact with multiple ligands, including CD155, CD112, and CD96. These interactions lead to the activation of downstream signaling pathways, such as the PI3K/AKT and MAPK pathways, which are involved in T cell and NK cell activation.
In addition to its role in immune response, CD226/DNAM-1 protein has also been implicated in the regulation of tumor growth and metastasis. It has been shown to promote the killing of tumor cells by NK cells and T cells, and its expression is often downregulated in various types of cancer.
Recombinant Mouse CD226/DNAM-1 Protein has a wide range of applications in both research and clinical settings. Here are some of the major applications of this protein:
CD226/DNAM-1 protein has been identified as a potential target for cancer immunotherapy. By enhancing the activity of NK cells and T cells, this protein can help in the elimination of tumor cells. Recombinant CD226/DNAM-1 protein can be used in combination with other immunotherapeutic agents to enhance their efficacy.
The ability of CD226/DNAM-1 protein to enhance T cell response makes it a potential candidate for vaccine development. Recombinant CD226/DNAM-1 protein can be used as an adjuvant to boost the immune response to vaccines.
The expression of CD226/DNAM-1 protein has been found to be altered in various types of cancer. As a result, it can serve as a potential biomarker for cancer diagnosis and prognosis. Recombinant CD226/DNAM-1 protein can be used in diagnostic tests to detect the levels of this protein in patient samples.
CD226/DNAM-1 protein has been implicated in the pathogenesis of several autoimmune diseases, such as multiple sclerosis and rheumatoid arthritis. Recombinant CD226/DNAM-1 protein can be used in drug discovery and development to identify potential inhibitors or modulators of this protein for the treatment of autoimmune diseases.
In summary, Recombinant Mouse CD226/DNAM-1 Protein is a crucial protein involved in immune response and has various applications in research and clinical settings. Its structure, activity and applications make it a promising target for cancer immunotherapy, vaccine development, and as a biomarker for
ProteoGenix catalogue number ARO-P11075. For research use only.
Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 28.20 kDa; Fragment: Thr26-Pro254; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
